NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

should a company legitimize every bash especially when they are a phony group that admittedly was attempting to short and evade litigation?

Especially true given the PhaseV disclaimer:

Phase Five Research Disclaimer:

By downloading this document you agree to the terms of this disclaimer. You agree and acknowledge that use of Phase Five Research’s research and its website is at your own risk. In no event should Phase Five Research or any affiliated party be liable for any direct or indirect trading losses caused by any information on this site. You further agree to do your own research and due diligence before making any investment decision with respect to securities covered herein.


You should assume that as of the publication date of any report on this site, Phase Five Research (along with or through its members, employees, affiliates and / or consultants and along with its clients and Investors) has a direct or indirect long or short investment position in the stock (and / or options of the stock) covered therein, and therefore stands to realize significant gains in the event that the price of the stock increases or declines. Following publication of any report, Phase Five Research (along with or through its members, employees, affiliates, and / or consultants and along with our clients and Investors) intend to continue transacting in the securities covered therein, and Phase Five Research (along with or through its members, employees, affiliates, and / or consultants and along with our clients and Investors) may be long, short, or neutral at any time hereafter regardless of its initial recommendation. All expressions of opinion are subject to change without notice, and the authors do not undertake the responsibility to update or supplement this report or any of the information contained herein.

The materials in this report not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. Phase Five Research has obtained all information contained herein and in reports from sources it believes to be accurate and reliable. Such information is presented “as is,” without warranty of any kind – whether express or implied. Phase Five Research makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. You should seek the advice of a securities professional regarding your stock transactions or purchase of securities. Any conclusions contained in any reports or materials available on this site are the opinion of Phase Five Research and are not statements of fact.

You agree that any dispute arising from your use of this website or viewing the material hereon shall be governed by the laws of the England and Wales, without regard to any conflict of law provisions. You knowingly and independently agree to submit to the personal and exclusive jurisdiction of the courts of London, England and waive your right to any other jurisdiction or applicable law. The failure of Phase Five Research to exercise or enforce any right or provision of these Terms of Service shall not constitute a waiver of this right or provision. If any provision of these Terms of Service is found by a court of competent jurisdiction to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties’ intentions as reflected in the provision and rule that the other provisions of these Terms of Service remain in full force and effect, in particular as to this governing law and jurisdiction provision. You agree that regardless of any statute or law to the contrary, any claim or cause of action arising out of or related to use of this website or the material herein must be filed within one (1) year after such claim or cause of action arose or be forever barred.